Pluri Inc
NASDAQ:PLUR

Watchlist Manager
Pluri Inc Logo
Pluri Inc
NASDAQ:PLUR
Watchlist
Price: 5.45 USD -9.77% Market Closed
Market Cap: 29.8m USD
Have any thoughts about
Pluri Inc?
Write Note

Pluri Inc
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Pluri Inc
Research & Development Peer Comparison

Comparables:
CLGN
KMDA
B
BLRX
URGN
B
BONS

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Pluri Inc
NASDAQ:PLUR
Research & Development
-$316k
CAGR 3-Years
71%
CAGR 5-Years
52%
CAGR 10-Years
N/A
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Research & Development
-$10.5m
CAGR 3-Years
-42%
CAGR 5-Years
-21%
CAGR 10-Years
N/A
Kamada Ltd
NASDAQ:KMDA
Research & Development
-$15.5m
CAGR 3-Years
-4%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
B
BioLine RX Ltd
TASE:BLRX
Research & Development
-$11.3m
CAGR 3-Years
3%
CAGR 5-Years
10%
CAGR 10-Years
-2%
Urogen Pharma Ltd
NASDAQ:URGN
Research & Development
-$53.6m
CAGR 3-Years
-4%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
B
Bonus Biogroup Ltd
TASE:BONS
Research & Development
-â‚Ş19.2m
CAGR 3-Years
-19%
CAGR 5-Years
-11%
CAGR 10-Years
-9%

See Also

What is Pluri Inc's Research & Development?
Research & Development
-316k USD

Based on the financial report for Jun 30, 2024, Pluri Inc's Research & Development amounts to -316k USD.

What is Pluri Inc's Research & Development growth rate?
Research & Development CAGR 5Y
52%

Over the last year, the Research & Development growth was 98%. The average annual Research & Development growth rates for Pluri Inc have been 71% over the past three years , 52% over the past five years .

Back to Top